Skip to main content
. 2017 Dec 31;36(4):358–367. doi: 10.23876/j.krcp.2017.36.4.358

Table 3.

Distribution of the study groups by the cutoff point for high cardiovascular risk

Parameter Hemodialysis patients (n=54) Healthy control (n=56) Chi-square P value
Hypertension 52 (96.3) 5 (8.9) 84.05 < 0.0001
Dyslipidemia 50 (92.6) 31 (55.4) 22.14 < 0.001
SBP, ≥ 140 mmHg 38 (70.4) 6 (10.7) 40.77 < 0.001
DBP, ≥ 90 mmHg 30 (55.6) 2 (3.6) 36.01 < 0.001
TG, ≥ 200 mg/dL 6 (11.1) 6 (10.7) 0.004 0.947
TC, ≥ 240 mg/dL 1 (1.9) 2 (3.6) 0.306 0.580
HDL-C, < 40 mg/dL 50 (92.6) 31 (55.4) 19.63 < 0.001
LDL-C, ≥ 160 mg/dL 1 (1.9) 1 (1.8) 0.001 0.979
LDL-C/HDL-C, ≥ 4 49 (90.7) 16 (28.6) 43.95 < 0.001
TC/HDL-C, ≥ 6 44 (81.5) 13 (23.2) 37.38 < 0.001
CK-MB, ≥ 25 U/L 3 (5.6) 2 (3.6) 0.249 0.617
hs-TnT, ≥ 0.016 μg/L 52 (96.3) 0 (0) 102.3 < 0.001

Values are presented as number (%).

CK-MB, creatine kinase-MB isoenzyme; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; hs-TnT, high-sensitivity troponin T; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.